Superiority
Tranexamic acid is a derivative of aminotoluene, is an anti-fibrinolytic hemostatic drug, hemostatic mechanism and aminocaproic acid, aminotoluene acid the same, but the role of stronger, the intensity of aminocaproic acid 7 to 10 times, 2-fold of aminotoluene, and the toxicity is similar.
Trimsonic acid chemical structure and lysine similar to the competitive inhibition of plasminogen on fibrin adsorption, to prevent its activation, protection of fibrinolytic enzyme is not degraded and dissolved, and ultimately achieve hemostatic effect. For the treatment of acute or chronic, localized or systemic primary fibrinolysis hyperthyroidism caused by a variety of bleeding, such as obstetric bleeding, renal bleeding, prostatic hypertrophy bleeding, hemophilia, tuberculosis, blood, liver, lung , Spleen and other visceral bleeding after surgery; can also be used for abnormal bleeding during surgery and so on.
Details
Tranexamic acid
Synaptic: trans-4- (aminomethyl) cyclohexanecarboxylic acid; tranexamic acid; aminomethylcyclohexanoic acid; antithrombotic ring acid; hemostatic acid; trimester acid C; trans- (Aminomethyl) cyclohexanecarboxylic acid; trans-aminocarbamic acid
English name: Amstat
TRANS-4-AMINOMETHYL-1-CYCLOHEXANECARBOXYLIC ACID; trans-4-aminomethylcyclohexane-1-carboxylate; TRANS-4- (AMINOMETHYL) CYCLOHEXANECARBOXYLIC ACID; TRANEXAMIC ACID; amstat; amcha; amikapron
CAS Number: 1197-18-8
Molecular formula: C8H15NO2
Molecular weight: 157.21
EINECS number: 214-818-2
Tranexamic acid is a derivative of aminotoluene, is an anti-fibrinolytic hemostatic drug, hemostatic mechanism and aminocaproic acid, aminotoluene acid the same, but the role of stronger, the intensity of aminocaproic acid 7 to 10 times, 2-fold of aminotoluene, and the toxicity is similar.
Trimsonic acid chemical structure and lysine similar to the competitive inhibition of plasminogen on fibrin adsorption, to prevent its activation, protection of fibrinolytic enzyme is not degraded and dissolved, and ultimately achieve hemostatic effect. For the treatment of acute or chronic, localized or systemic primary fibrinolysis hyperthyroidism caused by a variety of bleeding, such as obstetric bleeding, renal bleeding, prostatic hypertrophy bleeding, hemophilia, tuberculosis, blood, liver, lung , Spleen and other visceral bleeding after surgery; can also be used for abnormal bleeding during surgery and so on.
The clinical effect of tranexamic acid on insect bites, eczema dermatitis, simple purpura, chronic urticaria, artificial urticaria, poisoning rash and drug eruption is remarkable, such as erythroderma, scleroderma, SLE, erythema multiforme Herpes zoster and alopecia areata have a certain effect, the effect of hereditary angioedema is also better. Treatment of chloasma general medication about 3 weeks effective, 5 weeks markedly, 60 d a course of treatment. Each oral 0.25 ~ 0.5g, 3 to 4 times a day. A small number of patients can occur nausea, fatigue, itching, abdominal discomfort and diarrhea and other side effects, withdrawal symptoms disappeared.
Quality standard: BP2010 oral level
Hubei manufacturers factory direct stock supply inexpensive
KG Pharmaceutical grade powder white 25KG / barrel
China (Mainland)